Press release
Rheumatology Therapeutics Market Anticipated To Witness Robust Growth, Surpassing $53.88 Billion By 2029
Rheumatology Therapeutics
What Is the Current Rheumatology Therapeutics Market Size and Its Estimated Growth Rate?
The rheumatology therapeutics market has experienced strong growth recently. It will increase from $42.4 billion in 2024 to $44.61 billion in 2025, registering a CAGR of 5.2%. Key factors include the rise in rheumatologic conditions, global population aging, enhanced awareness of treatment choices, progress in biological therapies, and broader healthcare access in developing nations.
The rheumatology therapeutics market is anticipated to grow steadily, reaching $53.88 billion by 2029 at a CAGR of 4.8%. The growth is due to the shift towards personalized medicine, rising adoption of biosimilars in rheumatology, increased investment in research and development, integration of digital health technologies, and regulatory approvals for novel therapies. Trends include the growth of telemedicine, remote monitoring solutions, targeted therapies, patient-centric care models, and the expansion of biologic treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17246
How Are Emerging Segments Shaping the Rheumatology Therapeutics Market Landscape?
The rheumatology therapeutics market covered in this report is segmented -
1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications
Subsegments:
1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs
3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids
4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase
5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp
Which Growth Factors Are Influencing Rheumatology Therapeutics Market Expansion?
The growing incidence of autoimmune disorders is anticipated to fuel the rheumatology therapeutics market. Autoimmune diseases arise when the immune system erroneously targets the body's own tissues. The increase in such diseases is influenced by genetic, environmental, and lifestyle contributors, along with improved diagnostics and awareness. Rheumatology therapeutics are essential in managing symptoms, reducing inflammation, and minimizing tissue damage. For example, in June 2024, the Australian Institute of Health and Welfare reported that in 2022, about 514,000 individuals in Australia (2.0% of the population) were living with rheumatoid arthritis, contributing 2.0% to the overall disease burden and 16% of the musculoskeletal burden in 2023. Thus, the rising prevalence of autoimmune disorders is supporting market growth.
Who Are the Dominant Players Across Different Rheumatology Therapeutics Market Segments?
Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.
What Trends Are Expected to Dominate the Rheumatology Therapeutics Market in the Next 5 Years?
Leading players in the rheumatology therapeutics sector are working on developing new treatments, including intravenous (IV) formulations, to improve both treatment efficiency and patient convenience. An IV formulation is a medication administered directly into a vein via a needle or catheter. For example, in October 2023, Novartis AG, based in Switzerland, revealed that the FDA had approved Cosentyx as an IV formulation for treating adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). This formulation targets interleukin-17A (IL-17A) and is the only IV treatment for these conditions that is not based on tumor necrosis factor alpha (TNF-a).
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
Which Geographic Regions Are Expected to Dominate the Rheumatology Therapeutics Market in the Coming Years?
North America was the largest region in the rheumatology therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Rheumatology Therapeutics Market?
2. What is the CAGR expected in the Rheumatology Therapeutics Market?
3. What Are the Key Innovations Transforming the Rheumatology Therapeutics Industry?
4. Which Region Is Leading the Rheumatology Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rheumatology Therapeutics Market Anticipated To Witness Robust Growth, Surpassing $53.88 Billion By 2029 here
News-ID: 4044841 • Views: …
More Releases from The Business Research Company
Top Trends Transforming the Fluoropolymer Films Market Landscape in 2025: Techno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Fluoropolymer Films Industry Market Size Be by 2025?
The fluoropolymer films market has seen strong growth recently. It will expand from $2.5 billion in 2024 to $2.65 billion in 2025 at a CAGR of 5.7%. Growth drivers in the past included high thermal stability, electronics manufacturing…
Driving Digitally Printed Wallpaper Market Growth in 2025: The Role of Rising Ur …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Digitally Printed Wallpaper Market Size Growth Forecast: What to Expect by 2025?
The digitally printed wallpaper market has expanded rapidly in recent years. It will grow from $9.13 billion in 2024 to $10.26 billion in 2025, at a CAGR of 12.4%. Historic growth was fueled by interior design preferences,…
Top Market Shifts Transforming the Biodegradable Paper and Plastic Packaging Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Biodegradable Paper and Plastic Packaging Market Through 2025?
Over the past few years, we've witnessed a significant expansion in the size of the biodegradable paper and plastic packaging market. It is projected to rise from $12.97 billion in 2024 to $14.12 billion…
Acrylic Rubber Market Landscape to 2034: Key Forces Shaping the Next Decade of G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Acrylic Rubber Market Size By 2025?
The acrylic rubber industry has seen robust growth in the past few years. The market value, which is projected to escalate from $1.63 billion in 2024 to $1.74 billion in 2025, implies a compound annual growth rate (CAGR) of…
More Releases for Rheumatology
Understanding the Rheumatology Market: Segments & Scope
According to The Insight Partners, the rheumatology market is broadly segmented by:
• Drug class: nonsteroidal anti inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and disease modifying anti rheumatic drugs (DMARDs).
• Disease indications: rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis.
• Distribution channels: hospital pharmacies, retail pharmacies, online pharmacies.
• Geography: the usual regions (North America, Europe, Asia Pacific, South & Central America, etc.) with further country level breakdowns.
CAGR (Compound Annual Growth…
Increasing Autoimmune Disease Prevalence Drives Rheumatology Therapeutics Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Rheumatology Therapeutics Market Size Growth Forecast: What to Expect by 2025?
The market for rheumatology therapeutics has seen robust growth in the recent past. The market size is expected to expand from $42.4 billion in 2024 to $44.61 billion in 2025, marking a compound annual growth rate (CAGR) of…
Rheumatology Therapeutics Market to Hit $59.1 Billion by 2030
◉ Global Rheumatology Therapeutics Market Set to Reach USD 59.1 Billion by 2030, Driven by Aging Population and Innovation
The global rheumatology therapeutics market is poised for steady growth, projected to reach nearly USD 59.1 billion by 2030, expanding at a CAGR of 2.7% from 2024 to 2030, according to Maximize Market Research. This growth is fueled by an aging global population, rising prevalence of rheumatic diseases, and continuous advancements in…
Rheumatology Therapeutics Market 2023 Driving Factors Forecast Research 2029
Rheumatology Therapeutics market is anticipated to grow at a CAGR of 3.2% during the forecast period (2023-2030). Therapeutic drugs are used to slow down the progression of certain autoimmune rheumatic diseases such as rheumatic arthritis (RA). The increasing prevalence of RA globally has bolstered the launch of novel therapeutic agents and favorable refurbishment policies for high-cost treatment products are some of the factors driving the market growth. According to the…
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty
December 05-06, 2022 | Dubai, UAE
Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty
Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc.
Audience Profile:
· …
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology…
